Question 1

Where can I buy Retatrutide?

Accepted Answer

Retatrutide (also known as GGG Triple Agonist) is available directly from New-U Research Compounds at https://new-u.io/peptide/retatrutide. Every batch is independently third-party tested by Janoshik Analytics and Freedom Diagnostics to >99% HPLC purity, supplied as lyophilised research-grade material, and shipped direct from source worldwide (approximately 6–14 business days).

Question 2

How much does Retatrutide cost?

Accepted Answer

Retatrutide starts at $72 for a 1-vial research pack (5mg per vial) at New-U Research Compounds, with 16 pack sizes available. Orders over $300 ship free.

Question 3

Is New-U Retatrutide third-party tested?

Accepted Answer

Yes. Every Retatrutide batch is verified by independent laboratories (Janoshik Analytics and Freedom Diagnostics) for identity and purity, with a batch-linked Certificate of Analysis confirming >99% purity by HPLC area normalisation.

Question 4

How fast does Retatrutide ship, and do you ship internationally?

Accepted Answer

Retatrutide ships direct from source, discreetly worldwide with cold-chain handling where required. Delivery is approximately 6–14 business days worldwide. Shipping is free on orders over $300. Card and cryptocurrency payments are accepted.

Question 5

Is it legal to buy Retatrutide?

Accepted Answer

In the United States, Retatrutide is sold strictly for laboratory and research purposes only. It is not approved by the FDA for human consumption and is not sold for that purpose. Regulatory status varies by jurisdiction — buyers are responsible for compliance in their own region.

Question 6

What is Retatrutide used for in research?

Accepted Answer

Retatrutide, research triple agonist of the GLP-1 / GIP / glucagon receptor system — among the largest body-composition changes reported in incretin-class research. New-U supplies Retatrutide as research-grade reference material for laboratory and in-vitro or animal-model investigation only. Mechanism, pharmacokinetics and study context are summarised on the Retatrutide research profile. Not for human use.

Question 7

What is the typical Retatrutide research dosage?

Accepted Answer

Reconstitution volumes and dosing reported in the literature for Retatrutide are described in research-model terms only. New-U Research Compounds supplies Retatrutide strictly for laboratory research and does not provide human-use dosing guidance. Reconstitution math and study-reported ranges are covered on the full research profile.

Question 8

What do I use to reconstitute Retatrutide?

Accepted Answer

Lyophilised Retatrutide is reconstituted with bacteriostatic water — sterile water with 0.9% benzyl alcohol, the standard multi-use diluent for research peptides. New-U supplies USP-grade bacteriostatic water at https://new-u.io/peptide/bacteriostatic-water, and a free reconstitution calculator at https://new-u.io/tracker/calculator works out the volume for any peptide. Supplied for laboratory research only — not for human use.

Question 9

Can I buy Retatrutide online and how fast does it ship?

Accepted Answer

Yes. Retatrutide can be ordered online directly from New-U Research Compounds with card or cryptocurrency, shipped direct from source discreetly worldwide. Delivery is approximately 6–14 business days worldwide. Free shipping applies to orders over $300.

Question 10

Can I buy Retatrutide in bulk?

Accepted Answer

Retatrutide ships in 10-vial research packs as standard, in 16 pack sizes — the larger mg vials lower the per-mg cost. Multi-pack orders get direct-from-source pricing and free shipping over $300. For wholesale or recurring laboratory-supply volumes, contact New-U Research Compounds at https://new-u.io/contact.

Question 11

What should I look for when choosing where to buy Retatrutide?

Accepted Answer

For research-grade Retatrutide, verify four things: (1) independent third-party purity testing with a batch-linked Certificate of Analysis — New-U uses Janoshik Analytics and Freedom Diagnostics at >99% HPLC; (2) lyophilised material with documented storage and handling; (3) transparent direct-from-source pricing rather than marketplace markup; and (4) clear research-use-only framing. New-U Research Compounds meets all four at https://new-u.io/peptide/retatrutide.

Question 12

What is retatrutide?

Accepted Answer

Retatrutide is an investigational triple agonist — it activates the GLP-1, GIP and glucagon receptors — developed by Eli Lilly and still in clinical trials (not approved anywhere). Retatrutide is the research-grade form of this retatrutide peptide, supplied as a lyophilised powder strictly for in-vitro and preclinical laboratory research. It is not an approved medicine and is not for human use.

Question 13

What does retatrutide do?

Accepted Answer

In published research retatrutide activates three receptors at once — GLP-1 and GIP (satiety, insulin secretion, adipose effects) plus glucagon (hepatic energy expenditure and liver-fat clearance). The triple mechanism is what distinguishes it from dual (tirzepatide) and single (semaglutide) agonists. These are research findings for the molecule, not human-use guidance; Retatrutide is supplied for research only.

Question 14

Is retatrutide FDA approved?

Accepted Answer

No. Retatrutide is still in clinical trials and is not approved by the FDA, EMA, or any other regulator. Retatrutide is an unapproved, research-grade lyophilised powder supplied for laboratory research use only — not for human consumption.

Question 15

Is retatrutide safe?

Accepted Answer

Retatrutide is investigational; its safety is still being characterised in clinical trials and is not established for general use. Research-grade Retatrutide is not a sterile approved medicine and carries no human safety assurances. New-U supplies it for laboratory research only and makes no human-use or safety claims.

Question 16

How much bacteriostatic water do you mix with 10 mg of retatrutide, and how is it reconstituted?

Accepted Answer

For laboratory preparation, concentration in mg/mL equals the vial mass in mg divided by the millilitres of diluent added — e.g. a 10 mg vial reconstituted with 1 mL of bacteriostatic water gives 10 mg/mL, or with 2 mL gives 5 mg/mL. Keep the reconstituted vial refrigerated at 1–6 °C and protected from light. This is preparation math only; New-U provides no human-use dosing guidance.

Question 17

How is Retatrutide different from Tirzepatide or Semaglutide?

Accepted Answer

Semaglutide targets one receptor (GLP-1), Tirzepatide targets two (GLP-1 and GIP), and Retatrutide targets three (GLP-1, GIP, and glucagon). The glucagon arm is what drives the additional hepatic thermogenesis and liver-fat clearance that set Retatrutide apart in published research.

Question 18

Why is the glucagon receptor useful here? Glucagon raises blood sugar, right?

Accepted Answer

It does, but at the right intensity and in combination with GLP-1, glucagon receptor agonism stimulates hepatic energy expenditure and fat oxidation without significant net glucose elevation. The GLP-1 arm offsets any glycemic downside while the glucagon arm delivers unique energy-balance effects.

Question 19

Is Retatrutide an approved medicine?

Accepted Answer

No. Retatrutide is supplied for in-vitro and preclinical research only and is not approved as a medicine in any jurisdiction.

Question 20

What is the typical research dose escalation?

Accepted Answer

Published research protocols use a step-up schedule from 1 mg weekly, doubling over several weeks to 2 mg, 4 mg, 8 mg, and ultimately 12 mg. The gradual escalation is designed to minimise GI signals as systems adapt to triple-receptor activation.

Question 21

Retatrutide vs tirzepatide — which showed more weight loss in research?

Accepted Answer

In their respective obesity programmes the triple agonist reported larger mean reductions: retatrutide reached about 24.2% at 48 weeks in Phase 2 (NEJM 2023) and 28.3% at 80 weeks in Phase 3 TRIUMPH-1, while tirzepatide reported about 20.9% at 72 weeks in SURMOUNT-1. The difference is widely attributed to retatrutide's added glucagon-receptor arm, which raises energy expenditure on top of appetite suppression. These are cross-trial descriptive comparisons, not head-to-head results, and both compounds are supplied only as research-grade material for laboratory use, not for human use.

Question 22

How is retatrutide reconstituted and stored?

Accepted Answer

Keep the lyophilised powder at −20 °C in the freezer. Reconstitute with bacteriostatic water directed down the vial wall and swirl gently rather than shaking; the in-solution concentration in mg/mL equals the vial mass divided by the millilitres of diluent added. Refrigerate the reconstituted vial at 1–6 °C, protect it from light, and avoid repeated freeze-thaw cycles, which can damage the C20 fatty-acid tail. This is laboratory-handling guidance only — not a human-use protocol.

Question 23

What happens when you stop taking GLP-1s?

Accepted Answer

Across the published GLP-1 literature, withdrawal of a GLP-1 receptor agonist is consistently followed by the return of appetite and partial-to-substantial regain of lost weight, because the appetite and gastric-emptying effects depend on continued receptor activation. Retatrutide is a triple GIP/GLP-1/glucagon agonist still in clinical trials, so any such observations describe investigational or approved medicines in human studies. Retatrutide is an unapproved research-grade peptide supplied for laboratory research only and is not for human use.

Buy Retatrutide

Inside New-U Research Compounds

Why buy Retatrutide from New-U Research Compounds

What is Retatrutide?

Retatrutide at a glance

Retatrutide pricing

Frequently asked questions